In previous studies, internal jugular vein compression (IJVC) has demonstrated a reduction in axonal and vascular injury associated with traumatic brain injury (TBI) when used as a prophylactic measure. IJVC's effect on not only intracranial, but also intracochlear pressure, was hypothesized to potentiate blast-induced hearing injury (BIHI), and therefore would preclude its use as a prophylactic therapy for TBI.
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To test this theory, the authors exposed 20 Sprague-Dawley rats to a right-sided shock wave in which 10 had application of a custom IJVC collar prior to injury. All rodents received baseline and post-blast injury tympanic membrane examination, otoacoustic emissions (OAE) and cochlear histology.
Interestingly, IJVC was shown to significantly reduce tympanic membrane rupture, immediate temporary threshold shifts, permanent threshold shifts at one month from injury and cochlear hair cell destruction in those rats that had application prior to injury exposure.
In this study, IJVC prior to BIHI reduced both functional and structural inner ear pathology in a rodent model. This fascinating study proposes a new prophylactic mechanism that not only provides benefits for TBI mitigation, but also may revolutionize the approach to traumatic hearing injury in both the military and civilian population. 
